http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-580030-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5b9e5ca3a81e56928c9711b36124740 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00 |
| filingDate | 2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3afa47b35efe15fc5824fab2cc4588c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d309028a8db87fbaf358064ab6af4331 |
| publicationDate | 2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-580030-A |
| titleOfInvention | Methods of treatment using glycopegylated g-csf |
| abstract | Disclosed is the use of an amount of a peptide which is a covalent conjugate between a granulocyte colony stimulating factor ( G-CSF ) peptide and a polymeric modifying group, wherein said polymeric modifying group is covalently attached to said peptide at a glycosyl or amino acid residue of said peptide via a glycosyl linking group, wherein said amino acid residue is asparagine, threonine or serine, and wherein said polymeric modifying group is a water-soluble polymer ( poly(ethylene glycol )), in the manufacture of a medicament for preventing infection, for treating severe chronic or relative leukopenia, acute myeloid leukemia, AIDS or other immunodeficiency diseases, bacterial infections, heart diseases, angina, Hepatitis A, B and C, compromised immunity and compromised white blood cell production, idiopathic thrombocytopenia purpura, neutropenia, febrile neutropenia, thrombocytopenia, for preventing or reducing the occurrence of acute rejection of organ transplants in a patient, for improving heart function, for treating neurological diseases, Alzheimer's disease and other degenerative disorders. |
| priorityDate | 2007-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 858.